Role of dendritic cell‑derived exosomes in allergic rhinitis (Review)

Int J Mol Med. 2023 Dec;52(6):117. doi: 10.3892/ijmm.2023.5320. Epub 2023 Oct 27.

Abstract

Allergic rhinitis (AR) is a common pathological condition in otorhinolaryngology. Its prevalence has been increasing worldwide and is becoming a major burden to the world population. Dendritic cells (DCs) are typically activated and matured after capturing, phagocytosing, and processing allergens during the immunopathogenesis of AR. In addition, the process of DC activation and maturation is accompanied by the production of exosomes, which are cell‑derived extracellular vesicles (EVs) that can carry proteins, lipids, nucleic acids, and other cargoes involved in intercellular communication and material transfer. In particular, DC‑derived exosomes (Dex) can participate in allergic immune responses, where the biological substances carried by them can have potentially important implications for both the pathogenesis and treatment of AR. Dex can also be exploited to carry anti‑allergy agents to effectively treat AR. This provides a novel method to explore the pathogenesis of and treatment strategies for AR further. Therefore, the present review focuses on the origin, composition, function, and biological characteristics of DCs, exosomes, and Dex, in addition to the possible relationship between Dex and AR.

Keywords: allergic rhinitis; dendritic cells; exosomes; extracellular vesicles; intercellular communication.

Publication types

  • Review

MeSH terms

  • Allergens
  • Dendritic Cells
  • Exosomes*
  • Extracellular Vesicles*
  • Humans
  • Rhinitis, Allergic* / metabolism

Substances

  • Allergens

Grants and funding

This work was supported by grants Natural Science Foundation of China (grant no. 81700888), Guangdong Basic and Applied Basic Research Foundation (grant no. 2021A1515010971), Shenzhen Science and Technology Program for Basic Research (grant no. JCYJ20220531091417040), Shenzhen Science and Technology Program (grant no. JCYJ20210324142207019), Shenzhen Key Medical Discipline Construction Fund (grant no. SZXK039), Science and Technology Development Special Fund of Shenzhen Longgang District (grant nos. LGKCYLWS2019000864 and LGKCZSYS2019000046), Science and Technology Innovation Special-Technology Tackling Project of Shenzhen Longgang District (grant no. LGKCYLWS2022032).